Catalyst Wire Dossier Catalyst Wire Dossier

H1ssF-3928 mRNA-LNP

· National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H1ssF-3928 mRNA-LNP, covering 2025-10-31 to 2025-10-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults [Phase 1]

See pricing